MedPage Today
(12/20, Walsh) reports, "A week of wound debridement using maggots
cleared necrotic tissue more effectively than conventional debridement
in patients with chronic venous ulcers," according to a study
published online Dec. 19 in the Archives of
Dermatology. "At day eight of treatment, the percentage of the wound
area covered by slough was 54.5% in patients given maggot therapy,
compared with 66.5% (P=0.04) of the wound area in a control group."
Still, "there was no difference between the groups in percentage of the
necrotic tissue on the wound at day 15 (55.4% versus 53.8%, P=0.78),
which was the study's primary endpoint." This led the study authors to
suggest that therapy with maggots should stop once debridement is
complete.
In the study of 105 patients with leg ulcers that would not heal,
approximately "80 maggots were placed in a dressing over the wound twice
a week for two weeks," WebMD
(12/20, Mann) reports. The article goes on to point out that the Food
and Drug Administration "regulates the use of maggots, and they are only
available via prescription" in the US. "They are mainly used to treat
diabetic ulcers and pressure ulcers, but can also
have a role in treating post-surgery wounds that are slow to heal and
may become infected." Also covering the story are Reuters (12/20, Joelving) and Medscape (12/20, Hitt).
No comments:
Post a Comment